Alsakarneh S, Al Ta'ani O, Aburumman R, Mikhail I, et al. Risk of De Novo Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis Treated With IL-17A Inhibitors: A Population-Based Study. Aliment Pharmacol Ther 2025 Apr 7. doi: 10.1111/apt.70139.
PMID: 40192577